EP3621609
SANFETRINEM EÐA SALT EÐA ESTER ÞEIRRA TIL AÐ NOTA Í MEÐFERÐ VIÐ MÝKÓBAKTERÍU-SÝKINGU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.5.2018EP published:
27.7.2022EP application number:
18721053.9
EP translation filed:
30.8.2022Grant published:
15.10.2022EPO information:
European Patent Register
Max expiry date:
3.5.2038Expiry date:
3.5.2026Next due date:
31.5.2026
Title in English:
SANFETRINEM OR A SALT OR ESTER THEREOF FOR USE IN TREATING MYCOBACTERIAL INFECTIONLanguage of the patent:
English
Timeline
Today
4.5.2018EP application
27.7.2022EP Publication
30.8.2022Translation submitted
15.10.2022Registration published
3.5.2026Expires
Owner
Name:
GlaxoSmithKline Intellectual Property Development LimitedAddress:
GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
BARROS AGUIRRE, DavidAddress:
28760 Madrid, ES
Name:
BATES, Robert H.Address:
28760 Madrid, ES
Name:
GONZALEZ DEL RIO, RubenAddress:
28760 Madrid, ES
Name:
MENDOZA LOSANA, AlfonsoAddress:
28760 Madrid, ES
Name:
RAMÓN GARCÍA, SantiagoAddress:
50008 Zaragoza, ES
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
17382255Date:
8.5.2017Country:
EP
Classification
Categories:
A61K 31/403, A61K 45/06, A61P 31/06, A61P 31/08, A61K 31/133, A61K 31/424, A61K 31/43, A61K 31/454, A61K 31/496
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 22.4.2023
Expires: 3.5.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 19.4.2024
Expires: 3.5.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.5.2025
Expires: 3.5.2026
Payer: Árnason Faktor ehf.